# Endtidal Ethanol in Sclerotherapy

> **NCT02740855** · — · COMPLETED · sponsor: **Insel Gruppe AG, University Hospital Bern** · enrollment: 70 (actual)

## Conditions studied

- Ethanol Concentration

## Interventions

- **DEVICE:** Alcomed 3011®

## Key facts

- **NCT ID:** NCT02740855
- **Lead sponsor:** Insel Gruppe AG, University Hospital Bern
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04
- **Primary completion:** 2018-10
- **Final completion:** 2018-10
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2018-11-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02740855

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02740855, "Endtidal Ethanol in Sclerotherapy". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02740855. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*